期刊
ONCOLOGY AND THERAPY
卷 9, 期 2, 页码 255-265出版社
SPRINGER
DOI: 10.1007/s40487-021-00157-1
关键词
Cancer; COVID-19; Efficacy; mRNA; SARS-CoV-2; Toxicity; Vaccine; Viral vector
类别
COVID-19 has had a severe impact on oncology care and research, with the rollout of vaccines raising hopes of controlling the pandemic. However, new issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants also need to be addressed.
Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The rollout of COVID-19 vaccines in many parts of the world has raised hopes of controlling the pandemic. In this editorial, the authors outline key characteristics of the currently approved COVID-19 vaccines, provide a brief overview of key emerging issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants of concern, and review the available data related to the efficacy and side effects of vaccinating patients with cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据